NCT03984981

Brief Summary

The aim of this study is to assess and survey the quality of the process required to diagnose brain death in adult patients. This study of adult patients diagnosed brain dead or suspected of having brain death on the ICUs at the University Hospital Basel will be purely observational.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 3, 2019

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 6, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 13, 2019

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
Last Updated

May 26, 2021

Status Verified

May 1, 2021

Enrollment Period

1.7 years

First QC Date

May 6, 2019

Last Update Submit

May 25, 2021

Conditions

Keywords

diagnosis of brain death

Outcome Measures

Primary Outcomes (1)

  • adherence to the local brain death protocol ( = measurement tool) for the process of brain death diagnosis

    the local brain death protocol ( = measurement tool) requires 1.) exclusion of the following conditions: * shock (mean arterial blood pressure \> 60 mmHg, lactate \< 4 mmol/l) * hypothermia (temperature \> 35°C) * severe acidosis (pH \> 7.3) * hyperosmolarity (osmolarity \< 320 mmol/l) * severe electrolyte disorders (sodium \> 125 mmol/l, phosphate \> 0.3 mmol/l) * hypoglycemia (glucose \> 4 mmol/l) * hyperammonemia (ammonia \< 60 mumol/l) * uremia (urea \< 25 mmol/l) * prolonged effects of medication (muscle relaxants, sedatives, recreational drugs) * severe hypothyreosis 2.) clinical examination confirming: * fixed pupils (dilated or mid-dilated bilaterally) * absent vestibulo-ocular reflex * absent corneal reflex bilaterally * no reaction to painful stimulus bilaterally * absence of cough and gag reflex * absence of spontaneous breathing (apnea test)

    single time point assessment at baseline (after suspected brain death)

Secondary Outcomes (5)

  • number of physicians involved

    single time point assessment at baseline (after suspected brain death)

  • frequency of ancillary tests performed

    single time point assessment at baseline (after suspected brain death)

  • number of work-ups excluding suspected brain death

    single time point assessment at baseline (after suspected brain death)

  • number of diagnostic work-ups with insufficient performance and/or documentation

    single time point assessment at baseline (after suspected brain death)

  • years of clinical experience of physicians involved

    single time point assessment at baseline (after suspected brain death)

Interventions

Assessment of process required to diagnose brain death in adult patients (demographics, clinical, laboratory, imaging, and treatment data). No questionnaires or study visits will be used.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study population will consist of all adult (18 years or older) patients in whom brain death was suspected and/or diagnosed on the ICUs of the University Hospital Basel between January 1st 2008 and January 31st 2019.

You may qualify if:

  • patients with suspected and/or diagnosed brain death
  • adults 18 years and over

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinic for Intensive Care Medicine, University Hospital Basel

Basel, 4031, Switzerland

Location

MeSH Terms

Conditions

Brain Death

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesComaUnconsciousnessConsciousness DisordersNeurobehavioral ManifestationsNeurologic ManifestationsDeathPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Raoul Sutter, PD Dr. med

    Clinic for Intensive Care Medicine, University Hospital Basel

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 6, 2019

First Posted

June 13, 2019

Study Start

April 3, 2019

Primary Completion

December 31, 2020

Study Completion

December 31, 2020

Last Updated

May 26, 2021

Record last verified: 2021-05

Locations